[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. [2] Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30. [3] Chen Z, Fillmore CM, Hammerman PS, et al.Non-small-cell lung cancers:a heterogeneous set of diseases[J]. Nat Rev Cancer, 2014, 14(8): 535-546. [4] Wood SL, Pernemalm M, Crosbie PA, et al.The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets[J]. Cancer Treat Rev, 2014, 40(4): 558-566. [5] Miller KD, Nogueira L, Mariotto AB, et al.Cancer treatment and survivorship statistics, 2019[J]. CA Cancer J Clin, 2019, 69(5): 363-385. [6] Spier I, Holzapfel S, Altmüller J, et al.Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas[J]. Int J Cancer, 2015, 137(2): 320-331. [7] Frugoni F, Dobbs K, Felgentreff K, et al. A novel mutation in the POLE2 gene?causing combined immunodeficiency [J]. J Allergy Clin Immunol, 2016, 137(2): 635-638.e1. [8] Hogg M, Johansson E.DNA polymerase ε[J]. Subcell Biochem, 2012, 62: 237-257. [9] Zahurancik WJ, Baranovskiy AG, Tahirov TH, et al.Comparison of the kinetic parameters of the truncated catalytic subunit and holoenzyme of human DNA polymerase ?[J]. DNA Repair (Amst), 2015, 29: 16-22. [10] Miyabe I, Kunkel TA, Carr AM.The major roles of DNA polymerases epsilon and delta at the eukaryotic replication fork are evolutionarily conserved[J]. PLoS Genet, 2011, 7(12): e1002407. [11] Church DN, Stelloo E, Nout RA, et al.Prognostic significance of POLE proofreading mutations in endometrial cancer[J]. J Natl Cancer Inst, 2015, 107(1): 402. [12] Meng B, Hoang LN, McIntyre JB, et al. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium[J]. Gynecol Oncol, 2014, 134(1): 15-19. [13] Gonzalez-Villasana V, Fuentes-Mattei E, Ivan C, et al.Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer[J]. Clin Cancer Res, 2015, 21(9): 2127-2137. [14] Wang R, Ke ZF, Wang F, et al.GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9[J]. Cell Physiol Biochem, 2015, 35(3): 969-982. [15] Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T.Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma[J]. Br J Cancer, 2003, 89(7): 1270-1275. [16] Darlix A, Lamy PJ, Lopez-Crapez E, et al.Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?[J]. Int J Cancer, 2016, 139(10): 2299-2311. |